In a message posted on the social network X, the president described this as “great news” and emphasized that this result is the fruit of an investment to expand capacity, in a context of severe economic limitations and the tightening of the US blockade.

  The plant, now with greater capacity, is responsible for supplying 16 cytostatic drugs to the National Cancer Patient Care Program.

  Production will resume prioritizing those medications of greatest clinical criticality, according to the schedules agreed upon with the Ministry of Public Health.

  During a visit to the facility, the Minister of Public Health, Jose Angel Portal, noted that, despite economic constraints, the launch will help guarantee the supply of cancer medications.

  For her part, the president of BioCubaFarma, Mayda Maur, highlighted the strong alliance between the biopharmaceutical and healthcare sectors as an essential pillar for maintaining the supply of cancer medications to the Cuban population, despite the intensification of the economic, commercial, and financial blockade imposed by the United States.

jdt/rgh/mks